Outsourcing
07.03.2012
Role of China - China's importance to the global pharmaceutical sourcing industry is no longer in question. Now the issue is how to materialize China's potential value via partnership development. In the past 10 years, the cost to commercialize a new drug has increased to about $1.5 billion.
The change has driven the pharmaceutical outsourcing investment to about $36 billion in 2011 and grown the CRO/CMO (contract research organization/contract manufacturing organization) market dramatically, particularly in China and India.
more31.10.2011
Swiss drugs industry supplier Lonza is set to grow underlying sales and operating profit this year despite the strong Swiss franc as it benefits from robust demand from pharmaceutical groups, particularly at a plant in China.
more27.10.2011
The challenges facing the pharma industry today - impending patent cliff, pressure coming from pharmerging markets, etc. - make the playing field rife with opportunities for pharma service providers.
Innovation in the pharmaceuticals ingredients industry is being driven by ...
more26.10.2011
New Rules -The game has changed for the global pharmaceutical industry. Numerous forces are shaping this new pharmaceutical era: The rise of emerging markets, increasing price pressure and expiring patents are just some of the factors forcing pharmaceutical companies to change the way they operate and how they manage their value chain.
more24.10.2011
Patent cliff, the rise of "pharmerging" markets: These are just a few of the challenges the global pharmaceutical industry is facing. In order to ward off billions of dollars in losses, pharma companies will have to redesign their supply chains and become less squeamish about outsourcing more and more elements of their businesses.
more01.06.2010
No Risk - Whether you are outsourcing product development or manufacture, it is crucial to ensure that you have a clear understanding of all intellectual property aspects of the transaction, and that you put in place a well-drafted contract that protects your intellectual property (IP) and ensures adequate rights in relation to any new IP generated. A failure to do so can have many consequences, but at its worst it will mean that you won't own new IP that you had expected to own, and your confidential information could have found its way into the public domain.
more